Mark L. Rosenblum

Mark L. Rosenblum is a Board Member at NICO, and has over 25 years of experience in the healthcare industry. Mark has served as a subject matter expert in integrated specialty care, physician alignment and mentoring, and for the development of Disease Centers of Excellence and Institutes, especially Neuroscience and Cancer.

Previously, Rosenblum was the Founder and Co-Director of the Hermelin Brain Tumor Center at Henry Ford Health System. Mark developed and directed a multi specialty brain tumor center with 7800 visits, 2750 tumor board presentations, 40% of patients on clinical trials, and 750 new brain tumor patients annually. Mark also coordinated the national guidelines for metastatic brain tumors, helped to define the genetics of brain tumor formation and developed spinal radiosurgery for metastatic cancer.

Rosenblum has also served as an Independent Consultant for Navigant Consulting Inc., where they served as a subject matter expert in integrated specialty care, physician alignment and mentoring, and for the development of Disease Centers of Excellence and Institutes, especially Neuroscience and Cancer.

Mark L. Rosenblum has the following educational background:

-A residency in neurosurgery from the University of California, San Francisco

-A residency in surgery from the University of California, Los Angeles

-A staff associate position in oncology and cancer biology from the National Cancer Institute

-An internship in medicine from the University of Michigan

-A Doctor of Medicine (MD) from New York Medical College

-A Bachelor of Science (BS) in biology from Rensselaer Polytechnic Institute

Mark is also certified by the American Board of Neurological Surgery in Neurological Surgery.